Ms. Wanner’s IP due diligence experience includes:
- Representation of Teva Pharmaceuticals in connection with a global collaboration with Regeneron Pharmaceuticals to develop fasinumab.
- Representation of Teva Pharmaceuticals in connection with the acquisitions of Auspex Pharmaceuticals and Labrys Biologics.
- Representation of Hillhouse Capital in connection with investments in Gossamer Bio and Omniome.
- Representation of underwriters during initial public offerings and follow-on offerings for Viking Therapeutics, Cerus Corporation, Zogenix, Conatus Pharmaceuticals, Sunesis Pharmaceuticals, and Innocoll.
Ms. Wanner is a member of the California and New York State Bar Associations, the Bar Association of San Francisco and the American Intellectual Property Law Association.